Stereotactic Ablative Radiation Therapy for Abiraterone-Resistant, Oligoprogressive Metastatic Prostate Cancer

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Stereotactic Ablative Radiation Therapy for Abiraterone-Resistant, Oligoprogressive Metastatic Prostate Cancer	Castration-Resistant Prostate Cancer; Oligoprogressive	Recruiting	Not applicable	2024-04-12		NCT04838899

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Sunnybrook Health Sciences Centre	193

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Odette Cancer Centre	Toronto	Canada	2

Clinical trials